As of Feb 05
| -0.08 / -1.55%|
The 8 analysts offering 12-month price forecasts for Mesoblast Ltd have a median target of 13.09, with a high estimate of 21.54 and a low estimate of 4.71. The median estimate represents a +157.19% increase from the last price of 5.09.
The current consensus among 8 polled investment analysts is to Buy stock in Mesoblast Ltd. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.